The Fair Prescription Pricing Act would close that gap by barring group health plans and insurers from charging any deductible, coinsurance, or copayment for an in-network pharmacy drug above the drug's nationwide average price
I will cap patients' out-of-pocket prescription drug costs so in-network pharmacy charges do not exceed a drug's nationwide average price.
Occurrences
Evidence
unverified · Source version 55878 · locator unknown
Last Action Date Listed August 20, 2026 Action Ms. Scholten introduced the following bill; which was referred to the Committee on Energy and Commerce, and in addition to the Committees on Ways and Means, and Education and Workforce
verified · Source version 55880 · locator 1988
may not impose cost sharing (including deductibles, coinsurance, and copayments) with respect to a covered outpatient drug for which benefits are available under such plan or coverage dispensed by an in-network pharmacy in an amount that exceeds the nationwide average of consumer purchase prices for such drug
verified · Source version 55865 · locator 2240
The Fair Prescription Pricing Act would close that gap by barring group health plans and insurers from charging any deductible, coinsurance, or copayment for an in-network pharmacy drug above the drug's nationwide average price
Assessments
The verified commitment is an outcome promise to cap in-network prescription drug cost-sharing at or below the nationwide average price. Verified evidence shows Scholten introduced and promoted the Fair Prescription Pricing Act, and the bill text contains the promised cap mechanism. However, the verified passages establish only proposal/introduction, not enactment or implementation. Because introducing a bill does not fulfill an outcome promise and no deadline has expired, the outcome remains unresolved. The effort is attributable to Scholten, so the effort badge is warranted.